API Holdings says FY26 net loss fell 67% to ₹520 crore
In short
API Holdings, the parent of PharmEasy, said its consolidated net loss fell 67% to ₹520 crore in the fiscal year ended March. That is much better than the year before, based on the publisher summary.
This matters because the company is losing less money. The report does not say what caused the improvement or give the revenue figure.
What the reporting says
API Holdings, the parent of PharmEasy, reported that its consolidated net loss narrowed 67% to ₹520 crore in the fiscal year ended March, according to a publisher summary. The reporting points to a much smaller loss than before, but it does not state the revenue figure or what drove the improvement. The immediate implication is reduced losses, while the full business context remains unstated.
Why it matters
API Holdings, which owns PharmEasy, said its consolidated net loss narrowed to ₹520 crore for the fiscal year ended March, a 67% decline year on year. The source suggests an improvement in profitability, but it does not provide revenue, operating details, or the main reason for the smaller loss. Investors will likely focus on whether the company can keep cutting losses.